Profound Medical PROF Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 71.1%+0.3pp | 70.8%-1.7pp | 72.5%+3.1pp | 69.4%+1.8pp | 67.6%+1.8pp | |
| Operating margin | -202.6%+53.7pp | -256.3%+39.1pp | -295.4%+62.0pp | -357.4%-50.9pp | -306.4%+3.1pp | |
| Net margin | -206.8%+57.7pp | -264.4%+10.7pp | -275.2%+68.8pp | -344%-74.6pp | -269.4%-8.9pp | |
| EBITDA margin | -199.9%+52.9pp | -252.8%+37.8pp | -290.6%+60.4pp | -351%-51.7pp | -299.3%+1.5pp | |
| Returns | ||||||
| Return on equity | -70.6%-3.5pp | -67.1%+58.1pp | -125.2%-20.9pp | -104.2%-37.9pp | -66.4%-5.7pp | |
| Return on assets | -57.9%-0.3pp | -57.6%— | —— | —— | —— | |
| Return on invested capital | -295.1%+79.1pp | -374.1%— | —— | —— | —— | |
| Efficiency | ||||||
| Asset turnover | 0.3×+0.1× | 0.2×— | —— | —— | —— | |
| Inventory turnover | 0.7×0.0× | 0.7×— | —— | —— | 1.1×+0.5× | |
| Liquidity | ||||||
| Current ratio | 6.6×-6.0× | 12.5×+8.3× | 4.2×-4.3× | 8.5×-2.8× | 11.3×+0.8× | |
| Quick ratio | 5.7×-5.5× | 11.2×+7.8× | 3.3×-3.7× | 7.1×-3.0× | 10×+0.4× | |
| Cash ratio | 4.7×-5.1× | 9.8×+7.3× | 2.5×-3.7× | 6.1×-2.6× | 8.8×+0.4× | |
| Leverage | ||||||
| Debt-to-equity | 0.1×+0.1× | 0.1×-0.1× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Debt-to-assets | 0.1×0.0× | 0.1×-0.1× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Interest coverage | -38×+0.5× | -38.6×-4.6× | -34×-2.4× | -31.6×-6.0× | -25.6×-2.6× | |
| Per Share | ||||||
| Book value per share | $1.64-25.5% | $2.20+106% | $1.07-18.3% | $1.31-22.7% | $1.69-30.7% | |
| Valuation | ||||||
| Market capitalization | $241.65M+30.7% | $278.37M+89.4% | $146.96M-21.1% | $186.33M+6.6% | $174.83M-22.5% | |
| Enterprise value | $198.81M+28.7% | $223.36M+76.0% | $126.89M-18.6% | $155.95M+17.0% | $133.28M-24.2% | |
| Price / sales | 12.8×-2.8× | 17.3×+7.0× | 10.3×-5.5× | 15.7×+1.0× | 14.7×-6.4× | |
| Price / book | 4.1×-0.6× | 4.2×-0.4× | 4.6×-0.2× | 4.7×+1.3× | 3.4×-0.3× | |
| EV / sales | 10.6×-2.5× | 13.9×+5.0× | 8.9×-4.3× | 13.2×+1.9× | 11.2×-5.2× | |
| Earnings yield | -16.1%+5.9pp | -15.3%+11.5pp | -26.8%-4.9pp | -21.9%-3.6pp | -18.3%-5.9pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Profound Medical's profit margins?
- Profound Medical (PROF) runs a 71.1% gross margin and a -202.6% operating margin, with a -206.8% net margin.
- Where do Profound Medical's ratios come from?
- Every ratio is computed from Profound Medical's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
